Table 4.
Drug company R&D and non-R&D payments disclosed under the JPMA Transparency Guidelines and the ABPI Code (2018)
| JPMA payment categories | Value of payments, ($) | Value of payments –merged JPMA categories ( $) | Value of payments – merged JPMA – named recipients ($) | ABPI payment categories | Total value of payments ($) | Value of payments – named recipients ($) |
|---|---|---|---|---|---|---|
| Research and development (A) | 1,276,805,878.8 | 1,276,805,878.8 (100%) | 1,236,732,890.2 (96.9%) | Research and development | 493,470,880.7 (100%) | 0.0 (0%) |
| Scholarship donations (B1) | 167,048,419.4 | 217,575,581.0 (100%) | 217,575,581.0 (100%) | Donations and Grants | 35,118,661.8 (100%) | 35,082,449.0 (99.9%)1 |
| General donations (B2) | 34,517,905.3 | |||||
| Donations to academic and other societies (B3) | 16,009,256.3 | |||||
| Expenses related to co-sponsored conferences (B4) | 76,063,460.5 | 845,194,783.3 (100%) | 76,063,460.5 (10.0%) | Contributions to costs of events | 55,207,855.0 (100%) | 48,774,249.8 (88.3%) |
| Expenses for lecture conferences (D1) | 769,131,322.9 | |||||
| Lecture fees (C1) | 211,419,118.7 | 248,042,904.90 (100%) | 248,042,904.90 (100%) | Fees for service and consultancy | 74,931,974.0 (100%) | 53,459,921.3 (71.3%) |
| Manuscript writing fee/supervising fees (C2) | 8,973,254.3 | |||||
| Consulting/commissioning fees (C3) | 28,934,542.5 | |||||
| Other (C)2 | 161,435.2 | |||||
| Other expenses related to academic research support expenses (B5) | 11,203,780.9 | 12,621,124.4 (100%) | 11,203,780.9 (88.8%) | No corresponding ABPI payment categories | ||
| Other Information provision-related expenses (D4) | 1,417,343.5 | |||||
| Explanation meeting expenses (D2) | 275,045,094.6 | 275,045,094.6 (100%) | 0.0 (0%) | Excluded from or prohibited by disclosure requirements | ||
| Expenses for provision of literature and other products (D3) | 69,080,312.8 | 69,080,312.8 (100%) | 0.0 (0%) | |||
| Other expenses (E) | 42,814,875.4 | 42,814,875.4 (100%) | 0.0 (0%) | No corresponding ABPI payment categories | ||
| No corresponding JPMA payment categories | Joint working | 7,003,799.0 (100%) | 7,003,799.0 (100%) | |||
| Total | 2,988,626,001.0 (100%) | 2,988,626,001.0 (100%) | 1,791,064,063.3 (59.9%) | Total | 665,733,170.5 (100%) | 144,320,419.0 (21.7%) |
1 Until 2019 ABPI members could consent healthcare organisations before disclosing their payments but few companies chose to do so. Consenting healthcare organisations is currently prohibited
2 Originally, Category C did not have an "Other" item, but one company recorded the amount as "Other”